Clinical trial
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal…
NCT00107211 · Abramson Cancer Center at Penn Medicine, Other · Completed
Key facts
| NCT number | NCT00107211 |
|---|---|
| Title | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast |
| Official title | A HER-2/Neu Pulsed DC1 Vaccine for Patients With DCIS |
| Lead sponsor | Abramson Cancer Center at Penn Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Procedure |
| Interventions | therapeutic autologous dendritic cells, conventional surgery, neoadjuvant therapy |
| Enrollment | 30 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Apr 6, 2005 |
| Last update posted | Sep 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: